Additional information
Colourless liquid
103129-58-4
ACI-023407
NA
C26H32N2O5
452.54
Antidiabetic
Pharmaceutical Impurity Standards
Ethyl (2S)-2-[[(3S)-1-(2-ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]-4-phenylbutanoate
Ethyl (2S)-2-[[(3S)-1-(2-ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]-4-phenylbutanoate
1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, ethyl ester, [S-(R*,R*)]





![CETIRIZINE HYDROCHLORIDE METHYL ESTER (25 mg) (Methyl 2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetate dihydrochloride)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)